CSL en las noticias
Medicamentos y vacunas biotecnológicos
Tamtam encontró 13 artículos recientes sobre CSL.
- CSL shares: Buy, hold, or sell?
- Will CSL's Alentis Deal Reset Its Kidney Strategy (ASX:CSL)?
- CSL Limited (ASX:CSL): FY2026 Earnings Reflect Impairments and Biopharmaceutical Operations
- CSL vaccines unit slammed over UK compliance failures
- CSL vs CBA: Which ASX share is best for SMSFs?
- CSL to drop Terumo for Haemonetics in US plasma collection supply deal
- CSL Seqirus blasted for ‘multiple and prolonged deficiencies’
- Haemonetics shares jump as CSL sets 2027 rollout of plasma devices
- CSL (ASX:CSL) Backs Lixudebart As Investors Ask If The Undervalued View Still Holds
- CSL announces investment for share of Alentis rare kidney and liver candidate
- CSL Strikes New Deal as Shares Enjoy Rare Period Of Consolidation
- Australian Shares Flat; CSL Partners With Alentis Therapeutics to Develop Rare Kidney, Liver Disease Drug
- CSL signs deal with Trump administration to slash prices for its medicines
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como CSL?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares